RGD Reference Report - Irinotecan changes gene expression in the small intestine of the rat with breast cancer. - Rat Genome Database

RGD Reference Report - Irinotecan changes gene expression in the small intestine of the rat with breast cancer. - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

General

Irinotecan changes gene expression in the small intestine of the rat with breast cancer.
Authors:	Bowen, JM Gibson, RJ Cummins, AG Tyskin, A Keefe, DM
Citation:	Bowen JM, etal., Cancer Chemother Pharmacol. 2007 Feb;59(3):337-48. Epub 2006 Jun 24.
RGD ID:	2316088
Pubmed:	PMID:16799812 (View Abstract at PubMed)
DOI:	DOI:10.1007/s00280-006-0275-9 (Journal Full-text)
PURPOSE: The aetiology of mucositis is complex involving change in gene expression, altered apoptosis and interaction between epithelial and subepithelial compartments. This is the first investigation using microarray to assess chemotherapy-induced changes in the gut. The aims of this study were to identify genes that are altered by irinotecan, to determine how these genes contribute to apoptosis and to identify any potential gene families and pathways that are important for mucositis development. METHODS: Tumour-bearing female dark Agouti rats were administered twice with 150 mg/kg of irinotecan and killed 6 h after the final dose. Jejunal tissue was harvested and RNA was isolated. cDNA was synthesised and purified, prior to hybridisation and microarray analysis. A 5-K oligo clone set was used to investigate gene expression. Results from the microarray were quantified using RT-PCR. RESULTS: Many genes were significantly up- or down-regulated by irinotecan. In particular, multiple genes implicated in the mitogen-activated protein kinase (MAPK) signalling pathway were differentially regulated following treatment. These included interleukin 1 receptor, caspases, protein kinase C and dual-specificity phosphatase 6. RT-PCR was used to confirm effects of irinotecan on caspase-1 expression in jejunal tissue and was significantly increased 6 h after treatment with irinotecan. CONCLUSIONS: This study has identified MAP kinase signalling as being involved with irinotecan-induced intestinal damage and confirms previous findings with radiation-induced oral mucosal damage, which also implicated this pathway. Microarrays are emerging as a valuable tool in mucositis research by linking such findings. The common pathway of chemotherapy- and radiotherapy-induced damage, which utilises the caspase-cascade, may be a useful target to prevent apoptosis following cancer treatment.

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Notes	Source	Original Reference(s)
Dusp6	Rat	response to xenobiotic stimulus		IEP		irinotecan	RGD

Genes (Rattus norvegicus)


Dusp6 (dual specificity phosphatase 6)